Jun 04, 2020
Coronavirus (COVID-19) Update: FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study
Jun 03, 2020
Access announces Ultra Sonic Speed Results for SARS-CoV-2 Antibodies that is 100% sensitive and has an EUA from the FDA
Jun 03, 2020
Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE(TM) for the Treatment of Neuroblastoma
Jun 02, 2020
CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
Jun 02, 2020
Phlexglobal Providing Vital Support for COVID-19 Clinical Trials
Jun 01, 2020
Protalix BioTherapeutics Reports First Quarter 2020 Financial Results and Business Update
Jun 01, 2020
Federal judge enters order of permanent injunction against New York company for distributing unapproved drugs
Jun 01, 2020
Coronavirus (COVID-19) Update: Daily Roundup
May 29, 2020
Second Wave Concerns Create Urgent Need For Fast, Accurate Tests and Plausible Vaccines
May 29, 2020
Acupath Launches COVID19 Testing in NY and Beyond
May 29, 2020
Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
May 28, 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
May 28, 2020
DURECT to Present at the Jefferies 2020 Virtual Health Care Conference
May 28, 2020
Increasing Research and Collaborations in the $2,920 Million Dry Eye Medication Market, TBRC Report Suggests
May 28, 2020
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
May 28, 2020
FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
May 27, 2020
RegeneRx Advisory on Reclassification of Thymosin Beta 4 from Drug to Biologic
May 27, 2020
Moleculin Provides Update on Coronavirus Drug Development
May 27, 2020
CNS Provides Update on Development Agreement for WP1122
May 27, 2020
Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection